Tenax Therapeutics
Price & Volume
Stats
See more52W Range | $2.77-$7.89 |
Market Cap | $25.4M |
Shares Short | 419,502 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$13.05 |
News
See moreYahoo Finance • 13 days ago
Tenax Therapeutics Announces $25 Million Private Placement
Yahoo Finance • 13 days ago
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
Yahoo Finance • last month
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
About
CEO | Mr. Christopher T. Giordano |
CFO | Mr. Thomas A. McGauley |
Address | 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |
